|
US4181803A
(en)
*
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
|
ATE25078T1
(de)
*
|
1982-10-27 |
1987-02-15 |
Degussa |
2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
|
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
|
DE3665538D1
(en)
*
|
1985-01-23 |
1989-10-19 |
Asta Pharma Ag |
Synergistic combination of flupirtin and non-steroidal anti-phlogistics
|
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
|
ATE43789T1
(de)
*
|
1985-02-23 |
1989-06-15 |
Asta Pharma Ag |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika.
|
|
JP2583067B2
(ja)
*
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
|
GB8800199D0
(en)
*
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
|
MC2029A1
(fr)
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
|
US5629307A
(en)
*
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US6004945A
(en)
*
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
|
IN172468B
(cg-RX-API-DMAC7.html)
*
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
|
US5643921A
(en)
*
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
|
US5234947A
(en)
*
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
|
DE4200259A1
(de)
*
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
|
US5262419A
(en)
*
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5428039A
(en)
*
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
|
CA2195850A1
(en)
*
|
1994-08-03 |
1996-02-15 |
Guillaume Lebaut |
Substituted indoles
|
|
EP0788359B1
(en)
*
|
1994-09-22 |
2006-07-12 |
Richard Alan Smith |
Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders
|
|
US5679706A
(en)
*
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
|
EP1609477B1
(en)
*
|
1994-12-12 |
2011-11-09 |
Omeros Corporation |
Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
|
|
DE19539861A1
(de)
*
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
|
DE19701694A1
(de)
*
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
|
IN188411B
(cg-RX-API-DMAC7.html)
*
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
|
US5760007A
(en)
*
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
ATE308342T1
(de)
*
|
1997-08-08 |
2005-11-15 |
Chugai Pharmaceutical Co Ltd |
Arzneimittel gegen diabetes-komplikationen
|
|
US6265417B1
(en)
*
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
|
US6593335B1
(en)
*
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
|
US6211171B1
(en)
*
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
|
JP2000143510A
(ja)
|
1998-11-16 |
2000-05-23 |
Taisho Pharmaceut Co Ltd |
外用組成物
|
|
JP2002542147A
(ja)
*
|
1998-12-14 |
2002-12-10 |
セレジィ ファーマシューティカルス， インコーポレイテッド |
肛門直腸障害の処置のための組成物および方法
|
|
US6281211B1
(en)
*
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9903476D0
(en)
*
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
|
CA2359485A1
(en)
*
|
1999-03-10 |
2000-09-14 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
JP2003521468A
(ja)
|
1999-03-17 |
2003-07-15 |
シグナル ファーマシューティカルズ， インコーポレイテッド |
エストロゲンレセプタを変調させるための化合物及び方法
|
|
AT409083B
(de)
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
|
CN1230174C
(zh)
|
1999-07-06 |
2005-12-07 |
伊莱利利公司 |
治疗偏头痛的选择性iGluR5受体拮抗剂
|
|
US6472165B1
(en)
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
|
US6495550B2
(en)
*
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
|
WO2001010380A2
(en)
*
|
1999-08-04 |
2001-02-15 |
Icagen, Inc. |
Benzanilides as potassium channel openers
|
|
NZ527771A
(en)
*
|
1999-08-04 |
2005-04-29 |
Icagen Inc |
Methods for treating or preventing anxiety
|
|
US6117900A
(en)
*
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
US6383511B1
(en)
*
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
US6538004B2
(en)
*
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
|
US20020015730A1
(en)
*
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
TWI287984B
(en)
*
|
2000-10-17 |
2007-10-11 |
Wyeth Corp |
Pharmaceutical composition for modulating bladder function
|
|
US6589986B2
(en)
*
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
|
US6951863B2
(en)
*
|
2001-02-07 |
2005-10-04 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
|
|
US6469042B1
(en)
*
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
|
US20020183395A1
(en)
*
|
2001-04-04 |
2002-12-05 |
Wyeth |
Methods for treating hyperactive gastric motility
|
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
|
US6831087B2
(en)
*
|
2001-11-09 |
2004-12-14 |
Hoffmann-La Roche Inc. |
Pyridine substituted isoquinoline derivatives
|
|
KR100581309B1
(ko)
*
|
2002-02-05 |
2006-05-22 |
아스텔라스세이야쿠 가부시키가이샤 |
2,4,6-트리아미노-1,3,5-트리아진 유도체
|
|
WO2003068769A1
(en)
|
2002-02-12 |
2003-08-21 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
|
ATE533743T1
(de)
|
2002-05-17 |
2011-12-15 |
Janssen Pharmaceutica Nv |
Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1
|
|
WO2003106454A1
(en)
|
2002-06-12 |
2003-12-24 |
Orchid Chemicals & Pharmaceuticals Ltd |
1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
|
|
AUPS312602A0
(en)
*
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
EP1581510A4
(en)
*
|
2002-11-22 |
2006-08-30 |
Bristol Myers Squibb Co |
1-ARYL-2-HYDROXYETHYLAMIDEALS CALIUM CHANNEL OPENER
|
|
AU2003303484C1
(en)
*
|
2002-12-23 |
2012-06-14 |
Icagen, Inc. |
Quinazolinones as potassium channel modulators
|
|
ES2282701T3
(es)
|
2002-12-27 |
2007-10-16 |
H. Lundbeck A/S |
Derivados de 1,2,4-triaminobenceno utiles para tratar trastornos del sistema nervioso central.
|
|
JP2006520333A
(ja)
|
2003-03-14 |
2006-09-07 |
ハー・ルンドベック・アクチエゼルスカベット |
置換されたアニリン誘導体
|
|
EP1613303A1
(en)
|
2003-03-21 |
2006-01-11 |
H. Lundbeck A/S |
Substituted p-diaminobenzene derivatives
|
|
EP1631546A1
(en)
|
2003-04-25 |
2006-03-08 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
|
WO2004105795A1
(en)
|
2003-05-27 |
2004-12-09 |
Altana Pharma Ag |
Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
|
|
WO2005007111A2
(en)
*
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
US20050089473A1
(en)
*
|
2003-09-10 |
2005-04-28 |
Cedars-Sinai Medical Center |
Potassium channel mediated delivery of agents through the blood-brain barrier
|
|
US7799832B2
(en)
*
|
2003-10-23 |
2010-09-21 |
Valeant Pharmaceuticals North America |
Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
|
ES2235626B1
(es)
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
TW200530235A
(en)
*
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
TWI357901B
(en)
|
2004-03-12 |
2012-02-11 |
Lundbeck & Co As H |
Substituted morpholine and thiomorpholine derivati
|
|
RU2006139933A
(ru)
|
2004-04-13 |
2008-05-20 |
Икаген, Инк. (Us) |
Полициклические пиридины как модуляторы калиевых ионных каналов
|
|
BRPI0510593A
(pt)
*
|
2004-05-03 |
2007-11-20 |
Univ Duke |
composições para afetar a perda de peso
|
|
CN1984906A
(zh)
*
|
2004-07-15 |
2007-06-20 |
日本烟草产业株式会社 |
稠合苯甲酰胺化合物和香草素受体1(vr1)活性抑制剂
|
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
|
CA2580852A1
(en)
*
|
2004-09-21 |
2006-03-30 |
Synta Pharmaceutical Corp. |
Compounds for inflammation and immune-related uses
|
|
CA2589001A1
(en)
|
2004-11-19 |
2006-05-26 |
Kissei Pharmaceutical Co., Ltd. |
Preventive or therapeutic agent for neuropathic pain
|
|
EP1688141A1
(en)
*
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
AU2006220130B2
(en)
|
2005-03-03 |
2011-07-28 |
H. Lundbeck A/S |
Substituted pyridine derivatives
|
|
US7683058B2
(en)
*
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
|
EP1940406A4
(en)
*
|
2005-10-21 |
2009-11-18 |
Merck & Co Inc |
POTASSIUM CHANNEL INHIBITORS
|
|
PT2061465E
(pt)
|
2006-08-23 |
2013-07-15 |
Valeant Pharmaceuticals Int |
Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio
|
|
CA2670966A1
(en)
|
2006-11-28 |
2008-06-05 |
Valeant Pharmaceuticals International |
1,4 diamino bicyclic retigabine analogues as potassium channel modulators
|
|
US8563566B2
(en)
*
|
2007-08-01 |
2013-10-22 |
Valeant Pharmaceuticals International |
Naphthyridine derivatives as potassium channel modulators
|
|
JP5798115B2
(ja)
*
|
2009-06-22 |
2015-10-21 |
ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
置換ヒドロキサム酸およびその使用
|